Private Trust Company’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $90.7K | Sell |
1,003
-120
| -11% | -$11K | 0.01% | 1059 |
|
|
2025
Q4 | $101K | Sell |
1,123
-31
| -3% | -$2.94K | 0.01% | 1019 |
|
|
2025
Q3 | $114K | Buy |
1,154
+81
| +8% | +$8.03K | 0.01% | 973 |
|
|
2025
Q2 | $97.9K | Buy |
1,073
+137
| +15% | +$13.2K | 0.01% | 967 |
|
|
2025
Q1 | $106K | Buy |
936
+73
| +8% | +$7.81K | 0.01% | 926 |
|
|
2024
Q4 | $91.2K | Sell |
863
-109
| -11% | -$11.7K | 0.01% | 950 |
|
|
2024
Q3 | $105K | Buy |
972
+1
| +0.1% | +$109 | 0.01% | 904 |
|
|
2024
Q2 | $105K | Sell |
971
-101
| -9% | -$11.9K | 0.01% | 859 |
|
|
2024
Q1 | $141K | Sell |
1,072
-34
| -3% | -$4.25K | 0.02% | 754 |
|
|
2023
Q4 | $135K | Sell |
1,106
-4
| -0.4% | -$446 | 0.02% | 740 |
|
|
2023
Q3 | $125K | Buy |
1,110
+5
| +0.5% | +$635 | 0.02% | 723 |
|
|
2023
Q2 | $161K | Buy |
1,105
+83
| +8% | +$11.3K | 0.02% | 634 |
|
|
2023
Q1 | $132K | Sell |
1,022
-10
| -1% | -$1.26K | 0.02% | 673 |
|
|
2022
Q4 | $132K | Sell |
1,032
-112
| -10% | -$13K | 0.02% | 641 |
|
|
2022
Q3 | $120K | Sell |
1,144
-5
| -0.4% | -$549 | 0.02% | 616 |
|
|
2022
Q2 | $121K | Sell |
1,149
-1,657
| -59% | -$197K | 0.02% | 628 |
|
|
2022
Q1 | $359K | Sell |
2,806
-3,344
| -54% | -$403K | 0.06% | 269 |
|
|
2021
Q4 | $759K | Sell |
6,150
-83
| -1% | -$10.9K | 0.1% | 201 |
|
|
2021
Q3 | $886K | Sell |
6,233
-13
| -0.2% | -$1.91K | 0.13% | 180 |
|
|
2021
Q2 | $975K | Buy |
6,246
+21
| +0.3% | +$3.4K | 0.15% | 165 |
|
|
2021
Q1 | $967K | Sell |
6,225
-467
| -7% | -$72.3K | 0.16% | 156 |
|
|
2020
Q4 | $1M | Sell |
6,692
-1,856
| -22% | -$262K | 0.17% | 142 |
|
|
2020
Q3 | $1.13M | Buy |
+8,548
| New | +$1.12M | 0.22% | 116 |
|
|
2020
Q1 | – | Sell |
-5,409
| Closed | -$785K | – | 378 |
|
|
2019
Q4 | $785K | Sell |
5,409
-5
| -0.1% | -$690 | 0.15% | 158 |
|
|
2019
Q3 | $721K | Buy |
5,414
+3,414
| +171% | +$441K | 0.14% | 161 |
|
|
2019
Q2 | $228K | Buy |
+2,000
| New | +$234K | 0.05% | 332 |
|
|
2017
Q4 | – | Sell |
-1,997
| Closed | -$227K | – | 384 |
|
|
2017
Q3 | $227K | Sell |
1,997
-489
| -20% | -$56.4K | 0.05% | 340 |
|
|
2017
Q2 | $309K | Hold |
2,486
| – | – | 0.07% | 295 |
|
|
2017
Q1 | $294K | Sell |
2,486
-834
| -25% | -$94.5K | 0.07% | 298 |
|
|
2016
Q4 | $332K | Sell |
3,320
-627
| -16% | -$67.2K | 0.08% | 259 |
|
|
2016
Q3 | $498K | Buy |
3,947
+408
| +12% | +$50.4K | 0.12% | 199 |
|
|
2016
Q2 | $413K | Buy |
3,539
+4
| +0.1% | +$453 | 0.11% | 214 |
|
|
2016
Q1 | $365K | Buy |
3,535
+1,239
| +54% | +$120K | 0.1% | 236 |
|
|
2015
Q4 | $228K | Buy |
2,296
+69
| +3% | +$6.75K | 0.06% | 276 |
|
|
2015
Q3 | $203K | Buy |
2,227
+94
| +4% | +$9.42K | 0.06% | 295 |
|
|
2015
Q2 | $226K | Sell |
2,133
-21
| -1% | -$2.32K | 0.06% | 292 |
|
|
2015
Q1 | $245K | Sell |
2,154
-25
| -1% | -$2.85K | 0.07% | 282 |
|
|
2014
Q4 | $239K | Sell |
2,179
-3
| -0.1% | -$316 | 0.08% | 255 |
|
|
2014
Q3 | $213K | Sell |
2,182
-10
| -0.5% | -$984 | 0.07% | 272 |
|
|
2014
Q2 | $221K | Sell |
2,192
-168
| -7% | -$16.4K | 0.07% | 273 |
|
|
2014
Q1 | $217K | Hold |
2,360
| – | – | 0.08% | 237 |
|
|
2013
Q4 | $213K | Sell |
2,360
-309
| -12% | -$26.7K | 0.09% | 218 |
|
|
2013
Q3 | $213K | Hold |
2,669
| – | – | 0.1% | 205 |
|
|
2013
Q2 | $194K | Buy |
+2,669
| New | +$200K | 0.09% | 211 |
|
Other funds holding ZBH
VCM
VPM
Private Trust Company's ZBH Position: Q1 2026 in Review
Private Trust Company reduced its Zimmer Biomet (ZBH) stake by 11% in Q1 2026, selling an estimated $11K and leaving 1,003 shares worth $90.7K. The position accounts for 0.01% of the portfolio, ranked #1059.
Private Trust Company first reported a position in ZBH in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.13M in Q3 2020. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Private Trust Company held 1,003 shares of Zimmer Biomet worth $90.7K as of Q1 2026.
- Private Trust Company sold 120 Zimmer Biomet shares in Q1 2026, an estimated $11K.
- Zimmer Biomet made up 0.01% of Private Trust Company's portfolio in Q1 2026, its #1059 holding.
- Private Trust Company first reported a position in Zimmer Biomet in Q2 2013 and has held it in 44 quarters since.
- Private Trust Company's Zimmer Biomet position peaked at $1.13M in Q3 2020.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Private Trust Company's 13F filing for Q1 2026, filed 30 Apr 2026.